Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis

SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs. 1 Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a pred...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1980-12, Vol.303 (24), p.1400-1404
Hauptverfasser: Roberts, L. Jackson, Sweetman, Brian J, Lewis, Robert A, Austen, K. Frank, Oates, John A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1404
container_issue 24
container_start_page 1400
container_title The New England journal of medicine
container_volume 303
creator Roberts, L. Jackson
Sweetman, Brian J
Lewis, Robert A
Austen, K. Frank
Oates, John A
description SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs. 1 Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock. Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder. 2 , 3 After the recent demonstration that combined . . .
doi_str_mv 10.1056/NEJM198012113032405
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75328140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4315264271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</originalsourceid><addsrcrecordid>eNp9UE1Lw0AQXUSptfoLRAgIXiS6s985Sq1aaW1BPYft7kZTmkSzG6T_3i0tHkScwwzDe_N48xA6BXwFmIvrp9HjFDKFgQBQTAnDfA_1gVOaMobFPupjTFTKZEYP0ZH3SxwLWNZDPQFYKk76aDauTeu0dzaZt43tTCibOmmKzeaDflvp2pZ1ckuS2Oc6lK4OPvkqw3vyvPbBVaVJptqHxqxD40t_jA4KvfLuZDcH6PVu9DJ8SCez-_HwZpIaKlhIpSuU1XhBnSGcY2sKLLkWkgJTTkiriAYLxhEq7MLRjBVANJURNAYKtSADdLHV_Wibz875kFelN24V_bqm87nklChgOBLPfxGXTdfW0VsOSmRcUalYZNEty8S3feuK_KMtK92uc8D5Juz8j7Dj1dlOu1tUzv7c7NKN-OUWryqf125Z_av2DauAhaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1869583784</pqid></control><display><type>article</type><title>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</title><source>MEDLINE</source><creator>Roberts, L. Jackson ; Sweetman, Brian J ; Lewis, Robert A ; Austen, K. Frank ; Oates, John A</creator><creatorcontrib>Roberts, L. Jackson ; Sweetman, Brian J ; Lewis, Robert A ; Austen, K. Frank ; Oates, John A</creatorcontrib><description>SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs. 1 Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock. Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder. 2 , 3 After the recent demonstration that combined . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198012113032405</identifier><identifier>PMID: 6107852</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Acids ; Adult ; Animals ; Aspirin - administration &amp; dosage ; Aspirin - therapeutic use ; Biopsy ; Cardiac arrhythmia ; Case reports ; Chromatography ; Dyspnea ; Female ; Histamine ; Histamine H1 Antagonists - therapeutic use ; Histamine H2 Antagonists - therapeutic use ; Humans ; Male ; Mast Cells - metabolism ; Mastocytosis ; Middle Aged ; Pathogenesis ; Patients ; Primates ; Prostaglandin D2 ; Prostaglandins - biosynthesis ; Prostaglandins D - biosynthesis ; Prostaglandins D - urine ; Pruritus ; Retention ; Urine ; Urticaria Pigmentosa - drug therapy ; Urticaria Pigmentosa - metabolism ; Urticaria Pigmentosa - physiopathology</subject><ispartof>The New England journal of medicine, 1980-12, Vol.303 (24), p.1400-1404</ispartof><rights>Copyright Massachusetts Medical Society Dec 11, 1980</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</citedby><cites>FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</cites></display><links><openurl>$$Topenurl_article</openurl><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6107852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roberts, L. Jackson</creatorcontrib><creatorcontrib>Sweetman, Brian J</creatorcontrib><creatorcontrib>Lewis, Robert A</creatorcontrib><creatorcontrib>Austen, K. Frank</creatorcontrib><creatorcontrib>Oates, John A</creatorcontrib><title>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs. 1 Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock. Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder. 2 , 3 After the recent demonstration that combined . . .</description><subject>Acids</subject><subject>Adult</subject><subject>Animals</subject><subject>Aspirin - administration &amp; dosage</subject><subject>Aspirin - therapeutic use</subject><subject>Biopsy</subject><subject>Cardiac arrhythmia</subject><subject>Case reports</subject><subject>Chromatography</subject><subject>Dyspnea</subject><subject>Female</subject><subject>Histamine</subject><subject>Histamine H1 Antagonists - therapeutic use</subject><subject>Histamine H2 Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Mast Cells - metabolism</subject><subject>Mastocytosis</subject><subject>Middle Aged</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Primates</subject><subject>Prostaglandin D2</subject><subject>Prostaglandins - biosynthesis</subject><subject>Prostaglandins D - biosynthesis</subject><subject>Prostaglandins D - urine</subject><subject>Pruritus</subject><subject>Retention</subject><subject>Urine</subject><subject>Urticaria Pigmentosa - drug therapy</subject><subject>Urticaria Pigmentosa - metabolism</subject><subject>Urticaria Pigmentosa - physiopathology</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>false</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9UE1Lw0AQXUSptfoLRAgIXiS6s985Sq1aaW1BPYft7kZTmkSzG6T_3i0tHkScwwzDe_N48xA6BXwFmIvrp9HjFDKFgQBQTAnDfA_1gVOaMobFPupjTFTKZEYP0ZH3SxwLWNZDPQFYKk76aDauTeu0dzaZt43tTCibOmmKzeaDflvp2pZ1ckuS2Oc6lK4OPvkqw3vyvPbBVaVJptqHxqxD40t_jA4KvfLuZDcH6PVu9DJ8SCez-_HwZpIaKlhIpSuU1XhBnSGcY2sKLLkWkgJTTkiriAYLxhEq7MLRjBVANJURNAYKtSADdLHV_Wibz875kFelN24V_bqm87nklChgOBLPfxGXTdfW0VsOSmRcUalYZNEty8S3feuK_KMtK92uc8D5Juz8j7Dj1dlOu1tUzv7c7NKN-OUWryqf125Z_av2DauAhaA</recordid><startdate>19801211</startdate><enddate>19801211</enddate><creator>Roberts, L. Jackson</creator><creator>Sweetman, Brian J</creator><creator>Lewis, Robert A</creator><creator>Austen, K. Frank</creator><creator>Oates, John A</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19801211</creationdate><title>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</title><author>Roberts, L. Jackson ; Sweetman, Brian J ; Lewis, Robert A ; Austen, K. Frank ; Oates, John A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Acids</topic><topic>Adult</topic><topic>Animals</topic><topic>Aspirin - administration &amp; dosage</topic><topic>Aspirin - therapeutic use</topic><topic>Biopsy</topic><topic>Cardiac arrhythmia</topic><topic>Case reports</topic><topic>Chromatography</topic><topic>Dyspnea</topic><topic>Female</topic><topic>Histamine</topic><topic>Histamine H1 Antagonists - therapeutic use</topic><topic>Histamine H2 Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Mast Cells - metabolism</topic><topic>Mastocytosis</topic><topic>Middle Aged</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Primates</topic><topic>Prostaglandin D2</topic><topic>Prostaglandins - biosynthesis</topic><topic>Prostaglandins D - biosynthesis</topic><topic>Prostaglandins D - urine</topic><topic>Pruritus</topic><topic>Retention</topic><topic>Urine</topic><topic>Urticaria Pigmentosa - drug therapy</topic><topic>Urticaria Pigmentosa - metabolism</topic><topic>Urticaria Pigmentosa - physiopathology</topic><toplevel>peer_reviewed</toplevel><creatorcontrib>Roberts, L. Jackson</creatorcontrib><creatorcontrib>Sweetman, Brian J</creatorcontrib><creatorcontrib>Lewis, Robert A</creatorcontrib><creatorcontrib>Austen, K. Frank</creatorcontrib><creatorcontrib>Oates, John A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>no_fulltext</fulltext></delivery><addata><au>Roberts, L. Jackson</au><au>Sweetman, Brian J</au><au>Lewis, Robert A</au><au>Austen, K. Frank</au><au>Oates, John A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1980-12-11</date><risdate>1980</risdate><volume>303</volume><issue>24</issue><spage>1400</spage><epage>1404</epage><pages>1400-1404</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs. 1 Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock. Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder. 2 , 3 After the recent demonstration that combined . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>6107852</pmid><doi>10.1056/NEJM198012113032405</doi><tpages>5</tpages></addata></record>
fulltext no_fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1980-12, Vol.303 (24), p.1400-1404
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_75328140
source MEDLINE
subjects Acids
Adult
Animals
Aspirin - administration & dosage
Aspirin - therapeutic use
Biopsy
Cardiac arrhythmia
Case reports
Chromatography
Dyspnea
Female
Histamine
Histamine H1 Antagonists - therapeutic use
Histamine H2 Antagonists - therapeutic use
Humans
Male
Mast Cells - metabolism
Mastocytosis
Middle Aged
Pathogenesis
Patients
Primates
Prostaglandin D2
Prostaglandins - biosynthesis
Prostaglandins D - biosynthesis
Prostaglandins D - urine
Pruritus
Retention
Urine
Urticaria Pigmentosa - drug therapy
Urticaria Pigmentosa - metabolism
Urticaria Pigmentosa - physiopathology
title Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A25%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Production%20of%20Prostaglandin%20D2%20in%20Patients%20with%20Systemic%20Mastocytosis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Roberts,%20L.%20Jackson&rft.date=1980-12-11&rft.volume=303&rft.issue=24&rft.spage=1400&rft.epage=1404&rft.pages=1400-1404&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM198012113032405&rft_dat=%3Cproquest_cross%3E4315264271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1869583784&rft_id=info:pmid/6107852&rfr_iscdi=true